@article{article_306740, title={Is CHA2DS2-VASc Score different between patients with and without atrial fibrillation suffering from peripheral arterial embolism?}, journal={Medical Journal of Süleyman Demirel University}, volume={25}, pages={125–131}, year={2018}, DOI={10.17343/sdutfd.306740}, author={Emren, Sadık Volkan and Ada, Fatih and Aldemir, Mustafa and Onrat, Ersel}, keywords={Atrial Fibrillation, Thromboembolism, CHA2DS2-VASc score}, abstract={<p> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">Objective: </span> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">
CHA2DS2-VASc is a validated , </span> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">straightforward and practical stratification of </span> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">  thromboembolic risk score for  non-valvular atrial fibrillation (NVAF).
However it is usually used for stroke. In this trial we aim to compare the CHA2DS2-VASc
score between patients with and without AF suffering from peripheral arterial
embolism (PAE). </span> <br /> </p> <p> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">Materials and Methods: </span> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">
We retrospectively evaluated the data registries of 150 patients who admitted
to hospital due to PAE between January 2011- December 2016.  CHA2DS2-VASc score was
calculated for each patient </span> <br /> </p> <p> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">Results: </span> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">
Atrial fibrillation was detected 59% of patients.  Patients with AF were elder, more often
female gender, hypertension, heart failure, hyperlipidemia, stroke and
transient ischemic attack (p<0.05). The rate of prior PAE was similar between
two groups (p>0.05). Patients with AF had higher CHA2DS2-VASc
score then those without AF (5.1±1.7 vs 3.5±1.8 p<0.001).   The rate of the patients with a CHA2DS2-VASc
score 1-3  was higher in non-AF group
(41% vs 23% p=0.017. However the rate of the patients with a CHA2DS2-VASc
score score 7-9 was higher in AF group (28% vs 6% p<0.001). In-hospital
mortality was similar between groups (14% vs 7% p=0.235). </span> <br /> </p> <p> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">Conclusion: </span> <span lang="en-us" xml:lang="en-us" style="line-height:200%;">
Although AF patients had higher thromboembolic risk level based on CHA2DS2-VASc
score. The rate of prior PAE rate was similar between AF and non-AF groups. </span> </p>}, number={2}, publisher={Süleyman Demirel University}